A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Background: Small-cell lung cancer (SCLC), a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9–11 months for patients with extensive stage (EX-SCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://www.ncbi.nlm.nih.gov/pubmed/25353007
http://dx.doi.org/10.3389/fonc.2014.00271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://www.ncbi.nlm.nih.gov/pubmed/25353007
http://dx.doi.org/10.3389/fonc.2014.00271

Ejemplares similares